Morpholino

MO2-gldc

ID

ZDB-MRPHLNO-240219-12

Name

MO2-gldc

Previous Names

None

Target

gldc (1)

Sequence

5' - CTGAGAGACTGACTGAAATAACCAG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-gldc

No data available

Phenotype

Phenotype resulting from MO2-gldc

No data available

Phenotype of all Fish created by or utilizing MO2-gldc

Phenotype	Fish	Conditions	Figures
whole organism viability, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 1 from Weaver et al., 2022
pericardium edematous, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 1 from Weaver et al., 2022
cloaca pax2a expression increased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 5 from Weaver et al., 2022
pronephric proximal convoluted tubule slc20a1a expression decreased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 3 from Weaver et al., 2022
cloaca gata3 expression increased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 5 from Weaver et al., 2022
pronephric distal early tubule irx1a expression increased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 4 from Weaver et al., 2022
pronephric distal late tubule tbx2b expression decreased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 4 from Weaver et al., 2022
migratory cranial neural crest dlx2a expression spatial pattern, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 2 from Weaver et al., 2022
cloaca apoptotic process increased process quality, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 5 from Weaver et al., 2022
brain apoptotic process increased process quality, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 2 from Weaver et al., 2022
pronephric distal early tubule irx3b expression increased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 4 from Weaver et al., 2022
Meckel's cartilage morphology, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 1 from Weaver et al., 2022
pronephric distal late tubule tbx2a expression decreased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 4 from Weaver et al., 2022
cloaca increased area, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 5 from Weaver et al., 2022
pronephric proximal straight tubule multi-ciliated epithelial cell cimap1b expression increased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 3 from Weaver et al., 2022
pharyngeal arch decreased amount, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 1 from Weaver et al., 2022
ventricular system swollen, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 1 from Weaver et al., 2022
rhombomere 3 egr2b expression spatial pattern, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 2 from Weaver et al., 2022
pronephric distal late tubule slc12a3 expression decreased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 3 , Figure 6 from Weaver et al., 2022
pronephric distal late tubule mecom expression decreased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 4 from Weaver et al., 2022
pronephric distal early tubule slc12a1 expression increased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 3 , Figure 6 from Weaver et al., 2022
pronephros apoptotic process increased process quality, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 2 from Weaver et al., 2022
renal filtration decreased process quality, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 3 from Weaver et al., 2022
cloaca cell aggregated, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 5 from Weaver et al., 2022
cloaca mecom expression increased distribution, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 5 from Weaver et al., 2022
ventricular system increased volume, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 2 from Weaver et al., 2022
rhombomere mecom expression spatial pattern, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 2 from Weaver et al., 2022
head necrotic, abnormal	WT + MO1-gldc + MO2-gldc	control	Figure 1 from Weaver et al., 2022

Citations